32.60
-1.20
(-3.55%)
As of 12:21:45 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
143,530.00
143,530.00
1,626.00
1,435.00
Cost of Revenue
125,087.00
125,087.00
511.00
459.00
Gross Profit
18,443.00
18,443.00
1,115.00
976.00
Operating Expense
287,065.00
287,065.00
241,610.00
203,251.00
Operating Income
-268,622.00
-268,622.00
-240,495.00
-202,275.00
Net Non Operating Interest Income Expense
5,371.00
5,371.00
1,655.00
39.00
Pretax Income
-290,777.00
-290,777.00
-235,058.00
-198,637.00
Tax Provision
38,440.00
38,440.00
1,592.00
-12.00
Net Income Common Stockholders
-329,217.00
-329,217.00
-236,650.00
-198,625.00
Diluted NI Available to Com Stockholders
-329,217.00
-329,217.00
-236,650.00
-198,625.00
Basic EPS
-4.25
-4.25
-3.61
-2.12
Diluted EPS
-4.25
-4.25
-3.61
-2.12
Basic Average Shares
77,401.00
77,401.00
65,617.00
93,574.54
Diluted Average Shares
77,401.00
93,574.54
65,617.00
93,574.54
Total Operating Income as Reported
--
--
-240,495.00
-202,275.00
Total Expenses
412,152.00
412,152.00
242,121.00
203,710.00
Net Income from Continuing & Discontinued Operation
-329,217.00
-329,217.00
-236,650.00
-198,625.00
Normalized Income
-329,217.00
-329,217.00
-236,650.00
-198,625.00
Interest Income
5,842.00
5,842.00
1,687.00
189.00
Interest Expense
471.00
471.00
32.00
150.00
Net Interest Income
5,371.00
5,371.00
1,655.00
39.00
EBIT
-290,306.00
-290,306.00
-235,026.00
-198,487.00
EBITDA
-252,011.00
-252,011.00
-194,601.00
-156,863.00
Reconciled Cost of Revenue
125,087.00
125,087.00
511.00
459.00
Reconciled Depreciation
38,295.00
38,295.00
40,425.00
41,624.00
Net Income from Continuing Operation Net Minority Interest
-329,217.00
-329,217.00
-236,650.00
-198,625.00
Normalized EBITDA
-252,011.00
-252,011.00
-194,601.00
-156,863.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
12/31/2021 - 6/25/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6917.TWO Andros Pharmaceuticals Co.,Ltd
18.25
+0.83%
6652.TWO Eusol Biotech Co.,Ltd.
7.49
-3.97%
7729.TWO SBI
20.30
-4.02%
6999.TWO Han Biomedical
36.00
+3.75%
7776.TWO Anya
38.60
+7.67%
6709.TWO Advagene Biopharma Co., Ltd.
20.20
0.00%
6676.TWO Sunny Pharmtech Inc.
21.10
-2.28%
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
8.20
-0.12%
4197.TWO Visgeneer Inc.
9.78
0.00%
4170.TWO VBI
13.80
-1.43%